CAPTRUST Financial Advisors’s CorMedix CRMD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.6K	Buy	+10,685	New	+$79K	﹤0.01%	2854
2025 Q2	–	Sell	-11,013	Closed	-$67.8K	–	2530
2025 Q1	$67.8K	Sell	11,013 -103	-0.9%	-$1.07K	﹤0.01%	2266
2024 Q4	$90K	Buy	+11,116	New	+$111K	﹤0.01%	2211
2022 Q3	–	Sell	-1,679	Closed	-$7K	–	2474
2022 Q2	$7K	Buy	1,679 +179	+12%	+$665	﹤0.01%	3913
2022 Q1	$8K	Hold	1,500	–	–	﹤0.01%	3896
2021 Q4	$7K	Sell	1,500 -156	-9%	-$774	﹤0.01%	3896
2021 Q3	$8K	Sell	1,656 -785	-32%	-$4.57K	﹤0.01%	3723
2021 Q2	$17K	Buy	2,441 +941	+63%	+$7.49K	﹤0.01%	3210
2021 Q1	$15K	Buy	+1,500	New	+$15.8K	﹤0.01%	3184

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

CAPTRUST Financial Advisors's CRMD Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in CorMedix (CRMD) in Q1 2026: 10,685 shares worth $72.6K. The stake represents ﹤0.01% of the portfolio and ranks #2854 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in CRMD as recently as Q1 2025.

CAPTRUST Financial Advisors first reported a position in CRMD in Q1 2021 and has held it in 9 quarters since. The position peaked at $90K in Q4 2024. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

CAPTRUST Financial Advisors held 10,685 shares of CorMedix worth $72.6K as of Q1 2026.
CorMedix was a new CAPTRUST Financial Advisors position in Q1 2026.
CorMedix made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2854 holding.
CAPTRUST Financial Advisors first reported a position in CorMedix in Q1 2021 and has held it in 9 quarters since.
CAPTRUST Financial Advisors's CorMedix position peaked at $90K in Q4 2024.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.